首页
400-620-6333
抗体
选项
-
CA125 Mouse mAb关联靶标: MUC16
- 简短描述: mAb(4F8), Mouse anti Human CA125 Antibody; Detection antibody, ELISA, CLIA; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Mouse IgG2a
- 宿主种属: 小鼠(Mouse)
- 克隆号: 4F8
- 偶联: Unconjugated
-
CA125 Mouse mAb关联靶标: MUC16
- 简短描述: mAb(4A5), Mouse anti Human CA125 Antibody; Capture antibody, ELISA, CLIA; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Mouse IgG1
- 宿主种属: 小鼠(Mouse)
- 克隆号: 4A5
- 偶联: Unconjugated
-
Sofituzumab (anti-MUC16)关联靶标: MUC16
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 大鼠(Rat), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1615692-28-8 -
Pinatuzumab (anti-CD22)关联靶标: CD22
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1639820-81-7 -
Epratuzumab (anti-CD22)关联靶标: CD22
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG4SP
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 205923-57-5 -
Inotuzumab (anti-CD22)关联靶标: CD22
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1660159-36-3 -
CD22 Mouse mAb关联靶标: CD22
- 简短描述: mAb (HIB22); Mouse anti Human CD22 Antibody; Flow; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Mouse IgG1
- 宿主种属: 小鼠(Mouse)
- 克隆号: HIB22
- 偶联: Unconjugated
-
Sofituzumab vedotin (anti-MUC16)关联靶标: MUC16
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号 : 1418200-58-4 -
Pinatuzumab vedotin (anti-CD22)关联靶标: CD22
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human), 大鼠(Rat), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号 : 1313706-14-7 -
Moxetumomab (anti-CD22)关联靶标: CD22
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 1622075-65-3
